GoHealth, Inc.
GOCO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | -0.00 | 0.06 | 0.00 |
| FCF Yield | -60.39% | -69.07% | -12.14% | 9.11% |
| EV / EBITDA | -2.66 | -8.46 | 18.63 | 5.93 |
| Quality | ||||
| ROIC | 168.34% | -8.76% | 0.56% | 6.45% |
| Gross Margin | 41.22% | 65.54% | 89.36% | 86.58% |
| Cash Conversion Ratio | 0.19 | 0.33 | 1.27 | 0.25 |
| Growth | ||||
| Revenue 3-Year CAGR | 11.87% | 15.89% | 15.30% | 8.14% |
| Free Cash Flow Growth | 14.90% | -163.03% | -224.76% | 175.16% |
| Safety | ||||
| Net Debt / EBITDA | -2.44 | -7.66 | 14.86 | 4.64 |
| Interest Coverage | -11.63 | -5.87 | 0.42 | 4.53 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 2,537.94 | -11.30 | -216.21 | -120.18 |